K
Kara Punt
Researcher at Merck & Co.
Publications - 5
Citations - 2691
Kara Punt is an academic researcher from Merck & Co.. The author has contributed to research in topics: Simian immunodeficiency virus & Virus. The author has an hindex of 5, co-authored 5 publications receiving 2662 citations. Previous affiliations of Kara Punt include United States Military Academy.
Papers
More filters
Journal ArticleDOI
Replication-incompetent adenoviral vaccine vector elicits effective anti-immunodeficiency-virus immunity.
John W. Shiver,Tong-Ming Fu,Ling Chen,Danilo R. Casimiro,Mary-Ellen Davies,Robert K. Evans,Zhiqiang Zhang,Adam J. Simon,Wendy L. Trigona,Sheri Dubey,Lingyi Huang,Virginia Harris,Romnie Long,Xiaoping Liang,Larry Handt,William A. Schleif,Lan Zhu,Daniel C. Freed,Natasha Persaud,Liming Guan,Kara Punt,Aimin Tang,Minchun Chen,Keith A. Wilson,Kelly B. Collins,Gwendolyn J. Heidecker,V. Rose Fernandez,Helen C. Perry,Joseph G. Joyce,Karen M. Grimm,James C. Cook,Paul M. Keller,Denise S. Kresock,Henryk Mach,Robert D. Troutman,Lynne Isopi,Donna M. Williams,Zheng Xu,Kathryn E. Bohannon,David B. Volkin,David C. Montefiori,Ayako Miura,Georgia R. Krivulka,Michelle A. Lifton,Marcelo J. Kuroda,Jörn E. Schmitz,Norman L. Letvin,Michael J. Caulfield,Andrew J. Bett,Rima Youil,David C. Kaslow,Emilio A. Emini +51 more
TL;DR: The replication-defective adenovirus is a promising vaccine vector for development of an HIV-1 vaccine and elicited by a replication-incompetent Ad5 vector, used either alone or as a booster inoculation after priming with a DNA vector.
Journal ArticleDOI
Control of Viremia and Prevention of Clinical AIDS in Rhesus Monkeys by Cytokine-Augmented DNA Vaccination
Dan H. Barouch,Sampa Santra,Jörn E. Schmitz,Marcelo J. Kuroda,Tong-Ming Fu,Wendeline Wagner,Miroslawa Bilska,Abie Craiu,Xin Xiao Zheng,Georgia R. Krivulka,Kristin Beaudry,Michelle A. Lifton,Christine E. Nickerson,Wendy L. Trigona,Kara Punt,Dan C. Freed,Liming Guan,Sheri Dubey,Danilo R. Casimiro,Adam J. Simon,Mary-Ellen Davies,Michael Chastain,Terry B. Strom,Rebecca Gelman,David C. Montefiori,Mark G. Lewis,Emilio A. Emini,John W. Shiver,Norman L. Letvin +28 more
TL;DR: The protective efficacy of vaccine-elicited immune responses against a pathogenic SHIV-89.6P challenge in rhesus monkeys is reported, with no evidence of clinical disease or mortality after challenge.
Journal ArticleDOI
Attenuation of Simian Immunodeficiency Virus SIVmac239 Infection by Prophylactic Immunization with DNA and Recombinant Adenoviral Vaccine Vectors Expressing Gag
Danilo R. Casimiro,Fubao Wang,William A. Schleif,Xiaoping Liang,Zhiqiang Zhang,Timothy W. Tobery,Mary-Ellen Davies,Adrian B. McDermott,David H. O’Connor,Arthur Fridman,Ansu Bagchi,Lynda G. Tussey,Andrew J. Bett,Adam C. Finnefrock,Tong-Ming Fu,Aimin Tang,Keith A. Wilson,Minchun Chen,Helen C. Perry,Gwendolyn J. Heidecker,Daniel C. Freed,Anthony Carella,Kara Punt,Kara J. Sykes,Lingyi Huang,Virginia I. Ausensi,Margaret Bachinsky,Usha Sadasivan-Nair,David I. Watkins,Emilio A. Emini,John W. Shiver +30 more
TL;DR: The prophylactic efficacy of DNA and replication-incompetent adenovirus serotype 5 (Ad5) vaccine vectors expressing simian immunodeficiency virus (SIV) Gag was examined in rhesus macaques using an SIVmac239 challenge, and virus control was short-lived.
Journal ArticleDOI
Standardization of cytokine flow cytometry assays
Holden T. Maecker,Aline Rinfret,Patricia D'Souza,Janice Darden,Eva Roig,Claire Landry,Peter Hayes,Josephine Birungi,Omu Anzala,Miguel Garcia,Alexandre Harari,Ian Frank,Ruth Baydo,Megan Baker,Jennifer Holbrook,Janet Ottinger,Laurie Lamoreaux,C. Lorrie Epling,Elizabeth Sinclair,Maria A. Suni,Kara Punt,Sandra A. Calarota,Sophia El-Bahi,Gailet Alter,Hazel Maila,Ellen G. Kuta,Josephine H. Cox,Clive M. Gray,Marcus Altfeld,Nolwenn Nougarede,Jean D. Boyer,Lynda G. Tussey,Timothy W. Tobery,Barry M. Bredt,Mario Roederer,Richard A. Koup,Vernon C. Maino,Kent J. Weinhold,Giuseppe Pantaleo,Jill Gilmour,Helen Horton,Rafick Pierre Sekaly +41 more
TL;DR: ICS assays can be performed by multiple laboratories using a common protocol with good inter-laboratory precision, which improves as the frequency of responding cells increases.
Journal ArticleDOI
Intracellular Staining for HIV-Specific IFN-γ Production: Statistical Analyses Establish Reproducibility and Criteria for Distinguishing Positive Responses
Wendy L. Trigona,James H. Clair,Natasha Persaud,Kara Punt,Margaret Bachinsky,Usha Sadasivan-Nair,Sheri Dubey,Lynda Tussey,Tong-Ming Fu,John W. Shiver +9 more
TL;DR: The statistical criteria established by these analyses allow for the accurate detection and comparison of positive responses and conclude that the ICS assay is sufficiently robust for use in HIV-specific vaccine trials.